✦ LIBER ✦

Efficacy and safety of erlotinib HCl, an epidermal growth factor receptor (HER1/EGFR) tyrosine kinase inhibitor, in patients with advanced ovarian carcinoma: results from a phase II multicenter study

✍ Scribed by A.N. GORDON; N. FINKLER; R.P. EDWARDS; A.A. GARCIA; M. CROZIER; D.H. IRWIN; E. BARRETT

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II Safety and Efficacy Study of

✍ Pili, Roberto; Qin, Rui; Flynn, P.J.; Picus, Joel; Millward, Michael; Ho, Wing M 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 791 KB

A phase I dose escalation study of BIBW

✍ Eskens, F A L M; Mom, C H; Planting, A S T; Gietema, J A; Amelsberg, A; Huisman, 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 173 KB

Safety and efficacy of everolimus in Chi

✍ Jun Guo, Yiran Huang, Xu Zhang, Fangjian Zhou, Yinghao Sun, Shukui Qin… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 194 KB

Phase I, pharmacokinetic (PK) and biolog

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 145 KB

ZD1839 (‘Iressa’), an orally-active, sel

✍ G. Giaccone; J.L. Gonzales-Larriba; E.F. Smit; A.T. van Oosterom; M. Martins; G. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 338 KB

68O EFFICACY, SAFETY AND TOLERABILITY RE

✍ Douillard, J.; Ostoros, G.; Cobo, M.; Ciuleanu, T.; McCormack, R.; Webster, A.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 45 KB